Drugs / HydroVax-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02337868 | Mar 2015 → Dec 2016 | West Nile fever | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HydroVax-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02337868 ↗ |
| Modality | Vaccine | “inactivated vaccine” NCT02337868 ↗ |
| Route | Intramuscular | “IM on days 1 and 29” NCT02337868 ↗ |